Belpointe Asset Management LLC Akero Therapeutics, Inc. Transaction History

Belpointe Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$33.44 - $54.8 $57,851 - $94,804	1,730 New	1,730 $94,000
Q4 2021 Feb 15, 2022	SELL	$19.87 - $26.24 $434,954 - $574,393	-21,890 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $3,543 - $4,837	-190 Reduced 0.86%	21,890 $489,000
Q1 2021 May 14, 2021	BUY	$24.04 - $34.19 $530,803 - $754,915	22,080 New	22,080 $641,000

210

74.3M

321K

558K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.28B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.